DHA/AA Addition To Infant Formula Not Recommended By LSRO
This article was originally published in The Tan Sheet
Executive Summary
Evidence supporting the benefits of arachidonic acid and docosahexaenoic acid in term infant formulas is "insufficient" to warrant a recommendation that the long-chain polyunsaturated fatty acids be added to FDA's nutrient content standards for the products, the American Society for Nutritional Sciences Life Sciences Research Office concludes in a recent report.